⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 7, 2026Hepatology Research

Response to “Comment on ‘Anti‐MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray’”

J. Wada Kazumichi Abe Hiromasa Ohira

View at Publisher

Ask AI

Bookmark

Share

Key Points

Clarify points raised regarding the role of anti-MRPS27 antibody as a diagnostic biomarker for autoimmune hepatitis.
Engaged in a dialogue concerning previously published findings on anti-MRPS27 antibody.
No new data were created or analyzed in this response.
The response letter addresses specific comments without introducing new research or findings.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Response letter addressing a comment on the diagnostic potential of anti-MRPS27 antibody in autoimmune hepatitis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wada et al. (2026) studied this question.

synapsesocial.com/papers/6a2900566f82f25be989cf0b https://doi.org/10.1111/hepr.70214

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Anti‐MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome MicroarrayOriginal Research · 2026 · 3 citations
2Emerging Serological Biomarkers for Autoimmune HepatitisReview · 2026
3Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary CholangitisReview · 2026 · 1 citations
4Comments on “Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort”Original Research · 2026
5Novel autoantibodies in autoimmune hepatitis: from diagnostic challenges to molecular and spatial pathologyReview · 2026

Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis2004
Letter: Double <scp>PBC</scp> ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis?2026
Reply to Letter to the Editor: Regarding the “Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy”2024
An Integrative Multi‐Omic Biomarker Panel Distinguishes Hepatocellular Carcinoma From Chronic Liver Disease in HBV‐Predominant PopulationsHepatology Research · 2026
Differential Cardiometabolic Risk Profiles of Lean and Obese Metabolic Dysfunction–Associated Steatotic Liver Disease: A Longitudinal Health Checkup Cohort StudyHepatology Research · 2026

More from Hepatology Research

More from Fukushima Medical University